glp 1 blood clots Does semaglutide cause clots? What the research actually shows GLP-1 Therapies May Benefit MPN
Description
Nature Metabolism 2413431
Participants were admitted to a secure inpatient unit the night before the first dosing session to preclude acute intoxication
A 2023 SELECT trial determined that patients with pre-existing cardiovascular disease who used Wegovy over 39.8 months experienced the following events, compared to patients given a placebo
Were moving into seeing addiction on a continuum, and what looks like a gold standard treatment with one person has no effect on another because their individual makeup is different. Today, those treatments include self-help groups, behavioral therapies and residential rehabilitation facilities
GLP-1 RAs showed significant reductions in all anthropometric parameters, while SGLT2is was observed to improve WHR and AGF ratio (in addition to reduced body weight observed with SGLT2is/metformin combination)
Most people regain a significant portion of lost weight within 12 months of stopping, as the appetite-suppressing effect ends
